118 results in Exploration of Drug Science
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Short Communication
FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management
Muhammad Mazhar Azam ... Bibek Giri
Published: December 03, 2024 Explor Drug Sci. 2024;2:867–874
Open Access
Review
FDA-approved kinase inhibitors: a promising therapeutic avenue for traumatic brain injury
Dezhu Gao ... Weiming Liu
Published: December 2, 2024 Explor Drug Sci. 2024;2:851–866
This article belongs to the special issue Leveraging the FDA-Approved Kinase Inhibitors to Treat Neurological Disorders
Open Access
Review
Potential use of peptides mimicking CRAC/CARC domains as antivirulence therapies to inhibit RTX toxins activities
Vanesa Herlax
Published: November 20, 2024 Explor Drug Sci. 2024;2:836–850
This article belongs to the special issue Bioactive Peptides: Pioneering Innovations in Latin American Research
Open Access
Review
Technetium-99m-labeled peptides and their applications in radio imaging: advancements in Latin American research
Vaezeh Fathi Vavsari, Saeed Balalaie
Published: November 20, 2024 Explor Drug Sci. 2024;2:814–835
This article belongs to the special issue Bioactive Peptides: Pioneering Innovations in Latin American Research
Open Access
Review
Bio-mimetic strategies to re-activate apoptotic cell death for cancer treatments
Andrea Venerando ... Rossella De Marco
Published: November 11, 2024 Explor Drug Sci. 2024;2:785–813
This article belongs to the special issue Mimicking Nature: Biomimetics as Tools for Diagnosis and Therapeutics
Open Access
Review
Unlocking nature’s pharmacy: an in-depth exploration of phytochemicals as potential sources of anti-cancer and anti-inflammatory molecules
Shifana C. Sadiq ... Ruby John Anto
Published: October 30, 2024 Explor Drug Sci. 2024;2:744–784
This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer
Open Access
Mini Review
Lactoferrin: a secret weapon in the war against pathogenic bacteria
Lucero Ruiz-Mazón ... Mireya de la Garza
Published: October 21, 2024 Explor Drug Sci. 2024;2:734–743
This article belongs to the special issue Bioactive Peptides: Pioneering Innovations in Latin American Research
Open Access
Original Article
Bicyclic peptide-enhanced covalent inhibitor of SARS-CoV-2 3CL protease
Qian Wang ... Shiyu Chen
Published: October 17, 2024 Explor Drug Sci. 2024;2:719–733
This article belongs to the special issue Bioactive Peptides discovery and development
Open Access
Review
Synthetic peptides as valuable and versatile tools for research: our 20 year journey in Chile
Constanza Cárdenas ... Fanny Guzmán
Published: October 15, 2024 Explor Drug Sci. 2024;2:701–718
This article belongs to the special issue Bioactive Peptides: Pioneering Innovations in Latin American Research
Open Access
Perspective
Foundational contributions of Svetlana Mojsov to the GLP-1 field
George Barany, Michael J. Barany
Published: October 3, 2024 Explor Drug Sci. 2024;2:688–700
Open Access
Original Article
Prediction of absolute bioavailability of medicines in children: based on predicted pediatric clearance from adults
Iftekhar Mahmood
Published: September 30, 2024 Explor Drug Sci. 2024;2:677–687
Open Access
Review
Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
Yethindra Vityala ... Krishna Chaitanya Meduri
Published: September 30, 2024 Explor Drug Sci. 2024;2:666–676
Open Access
Review
21st century Latin American synthetic peptides for their application in antivenom production
Jésica A. Rodríguez ... Silvia A. Camperi
Published: September 30, 2024 Explor Drug Sci. 2024;2:648–665
This article belongs to the special issue Bioactive Peptides: Pioneering Innovations in Latin American Research
Open Access
Original Article
Properties of new polycationic bacteriochlorin photosensitizers: cytotoxicity and interaction with biofilms
Irina Tiganova ... Yulia Romanova
Published: September 27, 2024 Explor Drug Sci. 2024;2:632–647
This article belongs to the special issue Discovery and development of new antibacterial compounds
Open Access
Original Article
Hybrid peptides inspired by the RWQWRWQWR sequence inhibit cervical cancer cells growth in vitro
Natalia Ardila-Chantré ... Javier Eduardo García-Castañeda
Published: September 27, 2024 Explor Drug Sci. 2024;2:614–631
This article belongs to the special issue Bioactive Peptides: Pioneering Innovations in Latin American Research
Open Access
Review
Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
Tanya Tripathi ... Alok Chandra Bharti
Published: September 24, 2024 Explor Drug Sci. 2024;2:583–613
This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer
Open Access
Review
Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma
Sasikumar Jalajakumari Soumya ... Perumana R. Sudhakaran
Published: September 13, 2024 Explor Drug Sci. 2024;2:567–582
This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer
Open Access
Original Article
Clinical utility of combined contrast-enhanced ultrasound and intracavitary contrast-enhanced ultrasound in the percutaneous treatment of pyogenic liver abscess
Giampiero Francica
Published: September 13, 2024 Explor Drug Sci. 2024;2:555–566
This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
Open Access
Review
Chemo-selective modification of cysteine residue: synthesis and application in the discovery of potential drug candidates
Yanyan Liao, Xuefeng Jiang
Published: September 06, 2024 Explor Drug Sci. 2024;2:540–554
This article belongs to the special issue Bioactive Peptides discovery and development
Open Access
Review
A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules
Tejaswini Masne ... Deepali Bansode
Published: September 06, 2024 Explor Drug Sci. 2024;2:508–539
Journal Information